Aung Naing

R. Kurzrock

• University of Texas M.D. Anderson Cancer Center
• Department of Hematology
• Texas Children's Hospital
• Box 0422
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Box 302
• Unit 455
• Universityof Texas M. D. Anderson Cancer Center
• M.D. Anderson Cancer Center
• University of Texas at Austin
• University of Texas, M.D. Anderson Cancer Center
• Moores Cancer Center-University of California San Diego
• UT M.D. Anderson Cancer Cent.
• Division of Hematology-Oncology, UC San Diego Moores Cancer Center
• The University of Texas MD Anderson Cancer Center
• Phase I Program
• Univ. TX M.D. Anderson Cancer Ctr.
• Univ. Texas M. D. Anderson Cancer C.
• U.T. M.D. Anderson Cancer Center
• Univ. Texas M.D. Anderson Cancer C.
• University of California San Diego
• Box # 302
• Unit 422
• Box 422
• Division of Hematology and Oncology, Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Univesity of Texas
• M. D. Anderson Cancer Center
• University of Texas Health Science Center at Houston
• Clinical Immunology and Biological Therapy M.D. Anderson Cancer Center Houston
• Department of Investigational Cancer Therapeutics, University of Texas, M. D. Anderson Cancer Center
• Tumor Institute
• Univ of Texas, MD Anderson Canc Ctr
• Bristol-Myers Squibb
• Dana-Farber Cancer Institute
• UC San Diego Moores Cancer Center
• University of Texas MD Anderson Cancer Center
• UT-M. D. Anderson Cancer Center
• University of California at San Diego
• Repligen Corporation
• Johnson and Johnson Pharmaceutical Research and Development
• the University of Texas M.D. Anderson Hospital
• U. T. M. D. Anderson Cancer Center
• The University of Texas, M.D. Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• Exelixis
• Box 61
• Drexel University
• University of Texas Graduate School of Biomedical Sciences Houston
• Cancer Center, Box 41
• Unit 0455
• Moores Cancer Center - University of California San Diego
• FC8.2057
• A Phase I Program
• M.D. Anderson Hospital
• Anderson Hospital
• Dept. Hematol., Clin. Immunol., B.
• Worldwide Innovative Network in Personalized Cancer Medicine
• University of Texas MD Anderson Cancer Center
• UC San Diego Moores Cancer Center
• University of Tübingen
• Universidade Estadual de Campinas
• American Society of Clinical Oncology
• Department of Clinical Immunology and Biological Therapy
• Clinical Immunology
• University of Vienna
• The University of Chicago
• Johns Hopkins University
• Fox Chase Cancer Center
• Memorial Sloan-Kettering Cancer Center
• Shanghai Jiao Tong University
• Rambam Health Care Campus Israel
• Tel Hashomer Hospital
• Center for Personalized Therapy Clinical Trials Office
• Houston Clinical Trials
• University of California Office of the President
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• UCSD Moores Cancer Center
• University of California at San Diego Moores Cancer Center
• Division of Hematology and Oncology
• University of San Diego
• UCSD Moores Cancer Center
• Center for Personalized Cancer Therapy
• UC San Diego Medical Center
• Johnson & Johnson
• Department of Hematology
• Department of Bioimmunotherapy
• Department of Medicine
• Division of Hematology and Oncology
• Moores Cancer Center
• Department of Molecular Oncology
• Departments of Clinical Immunology and Biological Therapy
• Center for Personalized Therapy and Clinical Trials Office
• Phase I Program
• Experimental Therapeutics Program
• Moores Cancer Center
• Department of Investigational Cancer Therapeutics
• Department of Leukemia
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Internal Medicine
• Department of Medicine
• Department of Breast Medical Oncology
• The Departments of Clinical Investigation
• Department of Leukemia
• Phase I Program, Department of Investigational Cancer Therapeutics
• Department of Medicine
• Department of Cell Biology
• Center for Personalized Therapy and Clinical Trials
• Department of Gastrointestinal Medical Oncology
• Department of Hematology and Bone Marrow Transplantation
• Division of Hematology and Oncology
• Department of Experimental Therapeutics
• Cell Growth Regulation Laboratory
• Department of Medical Oncology
• Division of Hematology-Oncology
• Departments of Medical Ontology
• UC San Diego
• Division of Hematology and Oncology
• Clinical Center for Targeted Therapy
• Phase 1 Program
• Department of Bioimmunotheraphy
• Department of Clinical Investigations
• Dpt. Clin. Immun./Biol. Therap
• Section of Bone Marrow Transplantation
• Department of Cancer Medicine
• Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
• Departments of Leukemia and Bioimmunotherapy
• Department of Biologic Studies
• Departments of Neurosurgery and Hematopathology
• Dept. of Clinical Investigations
• Departments of Internal Medicine I and Nuclear Medicine
• Dept. Clin. Immun./Biol. Ther.
• Department of Clinical Investigation
• Department of Oncology
• M.D. Anderson Cancer Center
• Department of Experimental Therapeutics
• Departments of Experimental Therapeutics
• Department of Hematology and Oncology
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Investigational Cancer Therapeutics-a Phase I
• UC San Diego Moores
• Center for Personalized Therapy
• Division of Hematology/Oncology
• Worldwide Innovative Network (WIN) Association–WIN Consortium
• Department of Hematology/Oncology
• University of California at Berkeley
• Exelixis Inc.
• Biological Therapy
• Department of Clinical Immunology and Biological Therapy
• WIN Consortium
• University of Texas System
• WIN Consortium
• WIN Consortium
• Medical College of Wisconsin
• University of Nebraska Omaha
• Section of Leukocyte Biology
• WIN Consortium for Precision Medicine
• WIN Consortium for Personalized Cancer Therapy
• Equal Opportunity and Diversity Office

External person

Gerald S. Falchook

• University of Texas MD Anderson Cancer Center
• University of Texas, M.D. Anderson Cancer Center
• Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics, University of Texas MDAnderson Cancer Center
• Clinical Trials Program
• The University of Texas MD Anderson Cancer Center
• Baylor College of Medicine
• University of Texas at Austin
• Department of Investigational Cancer Therapeutics
• Unit 455
• University of Texas M.D. Anderson Cancer Center
• The University of Texas M. D. Anderson Cancer Center
• Sarah Cannon Research Institute at Healthone
• The University of Texas M.D. Anderson Cancer Center
• Sarah Cannon Research Institute at HealthONE, Presbyterian/St. Luke's Medical Center
• Institute at HealthONE
• Sarah Cannon Research Institute at Health ONE, Presbyterian/St. Luke's Medical Center
• Sarah Cannon Research Institute
• FC8.2018
• FC8.2057
• U.T. MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Houston Clinical Trials
• HealthOne
• Presbyterian-St. Luke's Medical Center
• Sarah Cannon Research Institute
• Unit 455
• University of California at San Diego
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Sarah Cannon Research Institute at HealthONE
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Sarah Cannon Research
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Investigational Cancer Therapeutics-a Phase I
• Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)
• Drug Development Program
• Drug Development Unit
• Drug Development Program
• University of Texas Health Science Center at Houston

External person

Sijin Wen

• UT MD Anderson Cancer Center
• M. D. Anderson Cancer Center
• West Virginia University
• West Virginia University Health Science Center
• University of Texas M.D. Anderson Cancer Center
• Universidade de São Paulo
• Univ. TX M.D. Anderson Cancer Ctr.
• MD Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• Unit 1374
• University of Texas MD Anderson Cancer Center
• Dana-Farber Cancer Institute
• University of Texas at Houston
• University of Texas at Austin
• David H. Koch Center for Applied Research of Genitourinary Cancers
• University of Texas MD Anderson Cancer Center
• Department of Biostatistics
• Quantitative Sciences Division
• Department of Biostatistics
• Department of Biostatistics
• Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
• Department of Biostatistics
• Department of Biostatistics
• Department of Biostatistics
• Departments of Neurosurgery and Hematopathology
• Departments of Biostatistics
• Department of Biostatistics
• School of Public Health
• Mary Babb Randolph Cancer Center
• Department of Genitourinary Medical Oncology
• Department of Biostatistics
• University of Montreal
• Memorial Sloan-Kettering Cancer Center
• Department of Leukemia
• Ludwig Center for Cancer Immunotherapy
• University of Texas Health Science Center at Houston

External person

Joud Hajjar

• Virginia Commonwealth University
• Baylor College of Medicine
• Texas Children's Hospital
• Section of Immunology
• Department of Immunology
• Departments of Internal Medicine
• Department of Immunology Allergy and Rheumatology
• Texas Children's Hospital Houston

External person

Kyriakos P. Papadopoulos

• START Center for Cancer Care
• Center for Cancer Care
• South Texas Accelerated Research Therapeutics (START)
• University of South Florida
• South Texas Accelerated Research Therapeutics
• South Texas Accelerated Research Therapeutics
• Astellas Pharma Inc.
• Clinical Research
• South Texas Accelerated Research Therapeutics
• Vanderbilt University
• Institute for Drug Development
• University of Texas Health Science Center at San Antonio
• START
• South Texas Accelerated Research Therapeutics
• Hematology/Oncology
• START San Antonio

External person

Ignacio Garrido-Laguna

• University of Texas MD Anderson Cancer Center
• Johns Hopkins University School of Medicine
• Unit 455
• University of Utah
• University of Texas M.D. Anderson Cancer Center
• FC8.2057
• Johns Hopkins University
• University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Huntsman Cancer Institute
• Huntsman Cancer Institute
• Sol Goldman Pancreatic Cancer Research Center
• Deparment Medical Oncology
• Department of Medicine
• Department of Medicine (Oncology)
• City of Hope National Med Center
• University of Texas Health Science Center at Houston

External person

Abdulrazzak Zarifa

• University of Texas MD Anderson Cancer Center
• Brookdale University Hospital and Medical Center

External person

Lacey McQuinn

• University of Texas Health Science Center at Houston
• University of Texas MD Anderson Cancer Center
• University of Evansville

External person

Karen A. Autio

• Oregon Health and Science University
• Memorial Sloan-Kettering Cancer Center
• Weil Cornell Medical College
• Cornell University
• Genitourinary Oncology Service
• Department of Medicine

External person

Patricia LoRusso

• Karmanos Cancer Institute/Wayne State University
• Wayne State University
• Karmanos Cancer Institute
• Barbara Ann Karmanos Cancer Center
• Wayne State University-Barbara Ann Karmanos Cancer Institute
• Baylor Health Care System
• Karmanos Cancer Center
• Pinnacle Oncology Hematology
• Yale University
• Yale Cancer Center
• Department of Medical Oncology
• Phase i Clinical Trials Program
• Eisenberg Center for Translational Therapeutics
• Yale School of Medicine
• Department of Medical Oncology
• Department of Breast Medical Oncology
• Yale New Haven Health System
• Smilow Cancer Hospital at Yale-New Haven

External person

Jing Gong

• University of Texas Health Science Center at Houston
• Huazhong University of Science and Technology
• Department of Biochemistry and Molecular Biology
• Department of Epidemiology and Biostatistics
• MOE Key Laboratory of Bioinformatics
• Tsinghua University
• Center for Synthetic and Systems Biology
• Tsinghua-Peking Center for Life Sciences
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Huazhong Agricultural University

External person

Annie Hung

• ARMO BioSciences
• Eli Lilly
• Biostatistics

External person

Johanna C. Bendell

• Sarah Cannon Research Institute
• Tennessee Oncology
• GI Oncology Research
• SCRI
• Drug Development Program
• Duke University
• Department of Pathology
• Tennessee Oncology PLLC
• SCRI, Tennessee Oncology, PLLC
• Department of Pathology
• Sarah Cannon
• Tennessee Oncology PLLC
• F. Hoffmann-La Roche AG

External person

Martin Oft

• ARMO BioSciences
• Eli Lilly
• Synthkine
• Pre-Clinical and Clinical Development
• a wholly owned subsidiary of Eli Lilly and Company

External person

Yang Ye

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics
• M. D. Anderson Cancer Center
• The University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Anas Alshawa

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Rabih Said

• University of Texas Health Science Center at Houston
• Department of Internal Medicine
• The University of Texas Health Science Center at Houston
• University of Texas at Austin
• University of Texas MD Anderson Cancer Center
• University of Balamand
• Department of General Internal Medicine
• Department of Oncology
• Department of Internal Medicine
• Memorial Hermann Cancer Center
• Division of Internal Medicine-Oncology
• Saint George Hospital University Medical Center

External person

Christian Rolfo

• Antwerp University Hospital
• Phase I - Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital
• Phase I- Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital
• University of Antwerp
• University of Colorado Denver
• Phase I - Early Clinical Trials Unit
• Phase I- Early Clinical Trials Unit
• Center for Oncological Research
• Division of Medical Oncology
• University of Maryland, Baltimore
• Thoracic Oncology
• Johns Hopkins University
• Thoracic Medical Oncology
• Hospital Universitario de Antwerp
• University of Colorado Anschutz Medical Campus
• Icahn School of Medicine at Mount Sinai

External person

Hung Le

• University of Texas MD Anderson Cancer Center
• Biostatistics
• Guy's and St.Thomas Hospital
• University of Texas Health Science Center at Houston

External person

Jeffrey R. Infante

• Sarah Cannon Research Institute
• Sol Goldman Pancreatic Cancer Research Center
• Tennessee Oncology
• Tennessee Oncology PLLC
• Wayne State University
• SCRI
• PLLC/SCRI
• SCRI, Tennessee Oncology, PLLC
• Tennessee Oncology
• Department of Surgery
• Department of Pathology
• Drug Development Program
• GI Oncology Research
• Janssen Inc
• Janssen Pharmaceuticals
• Sarah Canon Research Institute
• Tennessee Oncology PLLC
• Johnson & Johnson

External person

Joann Lim

• Department of Investigational Cancer Therapeutics
• University of Texas MD Anderson Cancer Center
• Pharamacy Clinical Programs
• University of Texas Health Science Center at Houston

External person

Deborah J L Wong

• University of California at Los Angeles
• Division of Hematology and Oncology

External person

Jing Gong

• China Medical University
• University of Texas Health Science Center at Houston
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Huazhong University of Science and Technology

External person

Todd M. Bauer

• Sarah Cannon Research Institute
• Tennessee Oncology
• Sarah Cannon Research Institute
• Tennessee Oncology PLLC
• Department of Drug Development
• PLLC
• Division of Medical Oncology
• Sarah Cannon Cancer Research Institute

External person

Joseph Leveque

• Amgen Inc.
• Amgen Incorporated
• ARMO BioSciencesRedwood City
• ARMO BioSciences
• Eli Lilly
• Scientific Affairs
• Scientific Affiars
• University of California at Los Angeles
• a Sanofi Company

External person

Ming Mo Hou

• Chang Gung University
• University of Texas MD Anderson Cancer Center
• Division of Hematology-Oncology
• Division of Hematology-Oncology
• Department of Hematology and Oncology
• University of Texas Health Science Center at Houston
• Chang Gung Memorial Hospital

External person

Jatin J. Shah

• University of Texas MD Anderson Cancer Center
• Department of Hematopathology
• Inc.
• University of Texas Health Science Center at Houston
• Inc.

External person

Kyaw Zin Thein

• University of Texas MD Anderson Cancer Center
• Texas Tech University Health Sciences Center
• Division of Hematology/Oncology
• Division of Hematology
• Division of Internal Medicine
• Oregon Health and Science University
• Comprehensive Cancer Centers of Nevada

External person

L. Austin Doyle

• University of Maryland Cancer Center
• University of Maryland, Baltimore
• National Institutes of Health
• Cancer Therapy Evaluation Program
• Cancer Therapy Evaluation Program
• Investigational Drug Branch

External person

Bulent Yilmaz

• University of Texas MD Anderson Cancer Center

External person

Helen X. Chen

• National Institutes of Health/National Cancer Institute
• CTEP National Cancer Institute
• National Institutes of Health
• University of Texas MD Anderson Cancer Center
• Cancer Therapy Evaluation Program
• Investigational Drug Branch

External person

Veronica R. Holley

• The MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Department of Investigational Cancer Therapeutics (Phase I Program)
• University of Texas Health Science Center at Houston

External person

Mehmet Asim Bilen

• Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center
• Baylor College of Medicine
• University of Texas M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• The University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Emory University
• Hacettepe University
• UT MD Anderson Cancer Center
• Section of Geriatrics
• Department of Hematology and Medical Oncology
• Department of Internal Medicine
• School of Medicine
• Univ. Texas MD Anderson Cancer Cent.
• Department of Hematology and Medical Oncology
• University of Texas Health Science Center at Houston

External person

Patrick A. Ott

• New York University
• Dana-Farber Cancer Institute
• Dana-Farber/Brigham and Women's Cancer Center
• Melanoma Center
• Perlmutter Cancer Institute
• Department of Medical Oncology
• Center for Immuno-Oncology
• Department of Hematology/Oncology
• Vanderbilt University
• Dana-Farber/Brigham and Women's Cancer Center
• Dana-Farber/Brigham and Women’s Cancer Center
• Harvard University
• Broad Institute
• 25Dana-Farber/Brigham and Women's Cancer Center
• Dana-Farber/Brigham and Women's Cancer Center
• Brigham and Women’s Hospital

External person

Kirk S. Culotta

• University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Biology
• Experimental Therapeutics
• Pharmacy Pharmacology Research
• Department of Experimental Therapeutics
• Merck
• University of Texas Health Science Center at Houston
• Experimental Therapeutics

External person

Yunfang Jiang

• University of Texas at Austin
• Univ. Tex. M.D. Anderson Cancer Ctr.
• U.T. MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Department of Lymphoma and Myeloma
• University of Texas Health Science Center at Houston

External person

Shumei Kato

• Department of Medicine
• University of California at San Diego
• Center for Personalized Therapy and Clinical Trials
• Department of Medical Oncology
• Moores Cancer Center
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Medicine
• Division of Hematology and Oncology
• Center for Personalized Cancer Therapy
• University of Texas MD Anderson Cancer Center

External person

Alexander I. Spira

• Virginia Cancer Specialists
• US Oncology, Inc.
• US Oncology Research
• US Oncology Research
• American Society of Clinical Oncology
• Oncology Program
• University of Michigan, Ann Arbor
• Johns Hopkins University
• US Oncology Network
• VA
• Virginia Cancer Specialists and US Oncology Research
• Virginia Cancer Specialists and NEXT Oncology Virginia
• Thoracic and Phase I Program
• Virginia Cancer Specialists
• US Oncology Network
• Co-Director

External person

Stacie Bean

• University of Texas MD Anderson Cancer Center
• Pharamacy Clinical Programs
• Department of Pharmacy

External person

Vanda M. Stepanek

• University of Texas MD Anderson Cancer Center
• The University of Texas MD Anderson Cancer Center
• University of Texas M.D. Anderson Cancer Center
• FC8.2018
• University of Texas MD Anderson Cancer Center
• Rice University
• M.D. Anderson Cancer Center
• Department of Bioengineering
• Department of Head and Neck Surgery
• University of Texas Health Science Center at Houston
• Rice University

External person

Nai Yi Shi

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Manish R. Patel

• Sarah Cannon Research Institute
• Sarah Cannon Research Institute
• Florida Cancer Specialists
• University of Minnesota Twin Cities
• Medical College of Wisconsin
• Ohio State University
• Sarah Cannon Research Institute

External person

Abulrahman Abonofal

• University of Texas MD Anderson Cancer Center
• West Virginia University

External person

Cynthia Uehara

• Department of Investigational Cancer Therapeutics
• University of Texas MD Anderson Cancer Center
• The University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center

External person

Roman Groisberg

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Department of Medical Oncology
• Rutgers Cancer Institute of New Jersey
• Department of Medical Oncology
• Rutgers - The State University of New Jersey, New Brunswick
• University of Texas Health Science Center at Houston
• Rutgers Cancer Institute of New Jersey
• Cancer Institute of New Jersey
• Rutgers University
• Merck

External person

Roman Yelensky

• Foundation Medicine
• University of California at San Diego
• Foundation Medicine, Inc
• Foundation Medicine, Inc.
• Foundation Medicine
• Foundation Medicine, Inc.
• Foundation Medicine
• Department of Clinical Development
• Foundation Medicine, Inc.
• Inc.

External person

Fechukwu Omolara Akhmedzhanov

• University of Texas MD Anderson Cancer Center

External person

Linda Zhong

• University of Texas MD Anderson Cancer Center

External person

Thorunn Helgason

• University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• University of Texas Health Science Center at Houston

External person

Raid Aljumaily

• Sarah Cannon Research Institute
• University of Oklahoma
• Department of Internal Medicine
• Stephenson Cancer Center
• Oncology
• Oklahoma University
• OUHSC

External person

Michael B. Atkins

• Harvard University
• Georgetown University
• Tufts University
• Division of Hematology-Oncology
• Eastern Oncology Group
• University of Michigan, Ann Arbor
• Dana-Farber/Harvard Cancer Center
• Department of Medicine
• Division of Hematology-Oncology and Cancer Biology
• Hematology-Oncology Division
• Department of Hematology and Oncology
• Division of Hematology and Oncology
• Center for Melanoma
• Division of Hematology Oncology
• Beth Israel Deaconess Medical Center
• University of Texas MD Anderson Cancer Center
• Department of Biostatistics
• Biol. Therapy/Cutaneous Oncol. Prog.
• American Society of Clinical Oncology
• Georgetown-Lombardi Cancer Center
• Department of Oncology
• Yeshiva University
• Beth Israel Deaconess Medical Center
• Massachusetts General Hospital Cancer Center
• MedStar Georgetown University Hospital
• Albert Einstein College of Medicine
• Division of Hematology/Oncology
• Albert Einstein College of Medicine

External person

Kevin B. Kim

• California Pacific Medical Center
• Melanoma Clinical Research Program
• University of Texas MD Anderson Cancer Center
• Melanoma Clinical Research Program
• University of Texas Health Science Center at Houston
• The University of Texas MD Anderson Cancer Center

External person

Murat Ak

• University of Pittsburgh

External person

Zhijie Wang

• Peking University Cancer Hospital and Institute
• Department of Thoracic Medical Oncology
• Chinese Academy of Medical Sciences
• University of Texas MD Anderson Cancer Center
• Translational Research (Ministry of Education
• Peking University
• Ministry of Education, China
• State Key Laboratory of Molecular Oncology
• Key Laboratory of Carcinogenesis
• Department of Medical Oncology
• University of Texas Health Science Center at Houston

External person

Joann Aaron

• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• University of Texas M.D. Anderson Cancer Center
• M D Anderson Cancer Center
• UT MD Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• University of Texas at Austin
• University of Texas MD Anderson Cancer Center
• Department of Community Oncology
• University of Texas Health Science Center at Houston

External person

Manish R. Patel

• Florida Cancer Specialists
• Sarah Cannon Research Institute
• Ohio State University
• Sarah Cannon Research Institute
• Drug Development Unit

External person

Priyadarshini Mamindla

• University of Pittsburgh

External person

Takeo Fujii

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston
• Department of Breast Medical Oncology
• Department of Biostatistics
• Department of Biostatistics
• Health Science Center
• University of Hawai'i at Mānoa
• Cold Spring Harbor Laboratory

External person

Bryan J. Schneider

• University of Michigan, Ann Arbor
• Virginia Cancer Specialists and US Oncology Research
• University of Michigan Rogel Cancer Center
• Division of Pulmonary and Critical Care Medicine
• Department of Internal Medicine

External person

Xiaochun Liu

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Nathaniel R. Wilson

• University of Texas Health Science Center at Houston
• University of Texas MD Anderson Cancer Center
• University of Texas Health Center at Tyler
• University of Michigan, Ann Arbor

External person

Robert E. Brown

• University of Texas at Austin
• University of Texas Health Sciences Center-Medical School
• University of Texas-Houston Medical School
• University of Texas Health Science Center at Houston
• University of Texas at Houston-Health Science Center
• UT Health-Department of Pathology and Laboratory Medicine
• MSB 2.286
• The University of Texas Medical School
• Baylor College of Medicine
• Department of Pathology and Laboratory Medicine, UT Health
• Department of Pathology and Laboratory Medicine
• Department of Pathology
• Department of Pathology and Laboratory Medicine
• Dept. of Pathol. and Lab. Medicine
• Department of Pathology
• The Department of Pathology
• Department of Pathology
• UT Health McGovern Medical School
• Internal Medicine
• UTHealth-Medical School at Houston

External person

Erick Campbell

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

John Wright

• Johnson and Johnson Pharmaceutical Research and Development
• Bristol-Myers Squibb
• National Institutes of Health, Bethesda
• National Institutes of Health
• University of Texas MD Anderson Cancer Center
• SUNY Upstate Medical University
• Johnson & Johnson
• Cancer Therapy Evaluation Program
• Clinical Treatment Evaluation Program
• Clinical Trials Evaluation Program
• Investigational Drug Branch
• Division of Cancer Treatment and Diagnosis
• Investigational Drug Branch
• Harvard University
• American College of Radiology
• Frederick National Laboratory for Cancer Research
• Cancer Therapy Evaluation Program
• Leidos Inc
• University of Texas Health Science Center at Houston
• Massachusetts General Hospital

External person

Goran Cabrilo

• The MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Department of Investigational Cancer Therapeutics (Phase I Program)

External person

Denis L. Jardim

• University of Campinas
• Department of Investigational Cancer Therapeutics, University of Texas MDAnderson Cancer Center
• Universidade Estadual de Campinas
• University of Texas MD Anderson Cancer Center
• Hospital Sirio-Libanes
• University of Texas at Austin
• Centro de Oncologia do Paraná
• Department of Clinical Oncology
• Department of Clinical Medicine
• University of Texas Health Science Center at Houston

External person

Amber M. Johnson

• UT MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
• Institute of Personalized Cancer Therapy
• Sheikh Khalifa Bin Zayed Al Nahyan
• University of Texas Health Science Center at Houston

External person

J. W. Moroney

• University of Texas M.D. Anderson Cancer Center
• WPAFB
• Wright State University
• University of Texas MD Anderson Cancer Center
• Wright-Patterson AFB
• Wright Patterson Medical Center
• Department of Obstetrics and Gynecology
• Departments of Gynecologic Oncology
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Wright Patterson Medical Center
• Department of Gynecologic Oncology
• Department of Gynecology
• Division of Gynecologic Oncology
• Chicago Consensus Working Group
• University of Texas Health Science Center at Houston
• The University of Chicago

External person

Lei Ye

• M.D. Anderson Cancer Center
• Shanghai Jiao Tong University
• Department of Endocrine Neoplasia and Hormonal Disorders
• Division of Internal Medicine
• Exelixis
• University of Texas M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Chemoprevention Branch
• The University of Chicago
• Johns Hopkins University
• Fox Chase Cancer Center
• Memorial Sloan-Kettering Cancer Center
• Department of General Internal Medicine, Ambulatory Treatment and Emergency Care
• Shanghai Key Laboratory for Endocrine Tumors
• Shanghai Center for Endocrinology and Metabolism
• Exelixis Inc.
• University of Texas Health Science Center at Houston

External person

John Powderly

• Carolina BioOncology Institute
• Carolina BioOncology Institute

External person

Adrienne Howard

• The University of Texas MD Anderson Cancer Center
• The University of Texas at Houston Health Science Center
• University of Texas Health Science Center at Houston
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)

External person

P. Van Vlasselaer

• Dendreon
• Stanford University
• Activated Cell Therapy
• ARMO BioSciences
• Eli Lilly

External person

Savita Bidyasar

• M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• VA Medical Center
• University of Texas Medical Branch at Galveston

External person

Raid Aljumaily

• University of Oklahoma
• Sarah Cannon Research Institute

External person

Agop Y. Bedikian

• M. D. Anderson Hospital
• M. D. Anderson Cancer Center
• University of Texas M.D. Anderson Cancer Center
• Univ. TX M.D. Anderson Cancer Ctr.
• Box 77
• The University of Texas M.D Anderson Hospital and Tumor Institute at Houston
• UT MD Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• Tumor Institute
• Hospital Sirio-Libanes
• M.D. Anderson Cancer Center
• Department of Melanoma Medical Oncology
• King Faisal Specialist Hospital and Research Section
• Baylor College of Medicine
• University of Texas MD Anderson Cancer Center
• Alfaisal University
• University of Texas at Austin
• Laboratory Medicine and Tumor Institute
• Department of Developmental Therapeutics
• Department of Melanoma
• Department of Melanotna/Sarcoma
• Departments of Developmental Therapeutics
• Department of Breast Medical Oncology
• Department of Melanoma/Sarcoma and Surgical Oncology
• Department of Medical Oncology
• Department of Medicine
• Department of Developmental Therapeutics and Department of Medicine
• Department of Developmental Therapeutics and Department of Radiology
• University of Texas Health Science Center at Houston
• King Faisal Specialist Hospital and Research Centre

External person

Israel Lowy

• Medarex, Inc.
• Medarex Corp.
• Medarex Corporation
• Regeneron Pharmaceuticals, Inc.
• Regeneron Pharmaceuticals

External person

Christos Vaklavas

• University of Alabama at Birmingham
• University of Texas Health Science Center at Houston
• Mayo Clinic Rochester, MN
• Department of Investigational Cancer Therapeutics
• University of Texas MD Anderson Cancer Center
• Department of Internal Medicine
• Division of Pediatrics
• Department of Hematology
• Department of Hematology and Oncology
• University of Utah

External person

Kristin L. Parkhurst

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• University of Texas Health Science Center at Houston

External person

Jeff Hosry

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston
• Department of Infectious Diseases
• Department of Infectious Diseases
• Department of Infectious Diseases

External person

Rajul K. Jain

• Amgen Inc.
• Amgen Incorporated
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Baylor College of Medicine
• University of Texas MD Anderson Cancer Center
• Department of Investi Gational Cancer Therapeutics (Phase i Program)
• Departments of Medicine and Pediatrics
• University of Texas Health Science Center at Houston

External person

Aya Albittar

• University of Texas MD Anderson Cancer Center
• SUNY Upstate Medical University

External person

F. Hirsch

• University of Liverpool
• University of Colorado Cancer Center
• University of Colorado Denver
• Data and Safety Monitoring Board
• University of Copenhagen
• University of Antwerp
• Emory University
• University of Colorado Anschutz Medical Campus
• University of Colorado Denver Cancer Center
• Division of Medical Oncology
• Harvard University
• Department of Medicine
• Department of Medicine
• University of Colorado Anschutz Medical Campus
• Department of Medical Oncology/Pathology
• Cancer Center
• Department of Pathology
• Department of Oncology
• Department of Medicine and Pathology
• Phase I - Early Clinical Trials Unit
• Department of Medicine
• Department of Medicine
• Department of Medical Oncology
• Department of Oncology
• International Association for the Study of Lung Cancer
• Department of Pathology
• Roy Castle International Centre for Lung Cancer Research
• Molecular Urology and Therapeutics Program
• Department of Medicine
• Division of Medical Oncology
• Icahn School of Medicine at Mount Sinai
• Center for Thoracic Oncology/Tisch Cancer Center
• Mount Sinai Health System
• Winship Institute
• Mount Sinai Hospital Medical Center
• Tisch Cancer Institute
• Mt. Sinai School of Medicine
• Mt. Sinai Cancer Center
• National Institutes of Health

External person

Matthew H. Taylor

• Oregon Health and Science University
• Knight Cancer Institute
• Case Western Reserve University
• Division of Hematology and Medical Oncology
• Providence Health System in Oregon
• Providence Portland Medical Center

External person

Philip J. Stephens

• Wellcome Research Laboratories, London
• Queen Mary Hospital
• Foundation Medicine
• Institute of Cancer Research
• University of California at San Diego
• Welcome Trust Sanger Institute
• Foundation Medicine, Inc
• The University of Hong Kong
• SUNY Albany
• Foundation Medicine, Inc.
• Foundation Medicine
• Wellcome Sanger Institute
• Wellcome Trust
• Foundation Medicine, Inc.
• Foundation Medicine
• Cancer Genome Project
• Cancer Genome Project
• Foundation Medicine
• Department of Clinical Development
• GRAIL Inc
• Foundation Medicine, Inc.

External person

W. Michael Korn

• UCSF Helen Diller Family Comprehensive Cancer Center
• University of California at San Francisco
• Department of Medicine
• Caris Life Sciences

External person

Ming Sun

• University of Texas MD Anderson Cancer Center
• Nanjing Medical University
• Department of Biochemistry and Molecular Biology
• Department of Oncology

External person

Cristina A. Reichner

• Georgetown University
• Georgetown University

External person

Andrés F. Cardona

• Instituto de Oncología Dr. Luis Razetti
• Clinical Epidemiology Clinical Research Coordinator
• Foundation for Clinical and Applied Cancer Research - FICMAC
• Institute of Oncology
• Fundación Santa Fe de Bogotá
• Hospital National Prof A. Posadas
• Instituto Nacional de Enfermedades Neoplásicas
• Astorga Clínica de Oncología
• Instituto Mexicano del Seguro Social
• Clinical and Translational Oncology Group
• Universidad El Bosque
• Foundation for Clinical and Applied Cancer Research - FICMAC
• Cl�nica del Country
• Clinical Research and Biology Systems Department
• Clinical and Translational Oncology Group
• Internal Medicine Department
• Centro Oncología San Peregrino
• Instituto Oncológico Luis Razetti
• F. Hoffmann-La Roche AG
• Clinical and Traslational Oncology Group
• Country Clinic
• Clínica Colsanitas
• Clinical Oncology Department
• Molecular Oncology and Biology Systems Research Group (Fox-G)
• Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center-CTIC
• Foundation for Clinical and Applied Cancer Research (FICMAC)

External person

Alessandro Russo

• Medical Oncology Unit
• A.O. Papardo
• University of Maryland, Baltimore
• University of Messina
• Papardo Hospital

External person

Luis H. Camacho

• Oncology Consultants
• Division of Clinical Research
• University of Texas M.D. Anderson Cancer Center
• St. Luke's Episcopal Hospital Cancer Center
• Unit 455
• MD Anderson Cancer Center
• University of California at Los Angeles
• University of Texas MD Anderson Cancer Center
• Baylor St. Luke's Medical Center
• St Luke's Medical Center
• Memorial Sloan-Kettering Cancer Center
• St. Luke's Episcopal Hospital
• Phase I Program
• Department of Breast Medical Oncology
• Department of Medical Oncology
• University of Texas Health Science Center at Houston

External person

K. Madwani

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Lilibeth Castillo

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Fengying Ouyang

• University of Texas MD Anderson Cancer Center

External person

H. Veasey Rodrigues

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Alexandra Drakaki

• University of California at Los Angeles

External person

Marc S. Ernstoff

• Dartmouth College
• University of Gottingen
• University of Göttingen
• Cleveland Clinic Foundation
• University Hospitals Seidman Cancer Center
• University Hospitals Seidman Cancer Center
• Case Western Reserve University
• University of Texas MD Anderson Cancer Center
• Roswell Park Cancer Institute
• Case Comprehensive Cancer Center
• Section of Hematology and Oncology
• Department of Medicine
• Department of Hematology and Oncology
• Roswell Park Comprehensive Cancer Center
• University of Pittsburgh
• Roswell Park Cancer Center
• National Institutes of Health
• Dartmouth Hitchcock Medical Center
• Dartmouth-Hitchcock Clinic
• SUNY Buffalo

External person

V. A. Miller

• Cornell University Medical College
• Foundation Medicine
• Weill Med. Coll. of Cornell Univ.
• Mem. Sloan Kettering Cancer Center
• Memorial Sloan-Kettering Cancer Ctr.
• Memorial Sloan-Kettering Can. Center
• Memorial Sloan-Kettering Cancer Center
• Mem. Sloan-Kettering Cancer Center
• M.D. Anderson Cancer Center
• Foundation Medicine, Inc
• Cornell University
• Med. Found., Inc.
• University of Texas MD Anderson Cancer Center
• SUNY Albany
• Foundation Medicine, Inc.
• Foundation Medicine
• Thoracic Oncology Service
• Thoracic Surgery Service
• Foundation Medicine, Inc.
• Foundation Medicine
• Division of Solid Tumor Oncology
• Department of Surgery
• Thoracic Oncology Service
• Molecular Biology Laboratory
• Department of Clinical Development
• Medical Oncology/Solid Tumor Program
• Thoracic Oncology Service, Division of Solid Tumor Oncology
• Department of Medicine
• Department of Medicine
• Lab. for Molecular Therapeutics
• Foundation Medicine, Inc.

External person

Justin T. Moyers

• University of Texas MD Anderson Cancer Center
• University of California at Irvine
• Angeles Clinic and Research Institute
• Cedars-Sinai Medical Center

External person

Muhammad Rizwan Khawaja

• University of Texas at Austin
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (A Phase i Program)
• University of Texas Health Science Center at Houston

External person

Alan L. Myers

• University of Texas, M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Pharmacy
• Department of Pharmacy Research
• University of Texas at Austin
• Health Science Center at Houston
• University of Texas Health Science Center at Houston
• Department of Diagnostic and Biomedical Sciences

External person

Zev A. Wainberg

• University of California at Los Angeles
• Division of Hematology/Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• University of Texas MD Anderson Cancer Center

External person

Shiraj Sen

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Sarah Cannon Research Institute
• HealthOne
• Sarah Cannon Research Institute

External person

J. Y. Fok

• University of Texas M.D. Anderson Cancer Center
• Clinical Trials Program
• Unit 455
• University of Texas MD Anderson Cancer Center
• Houston Clinical Trials
• Cytokine Research Laboratory
• Department of Investigational Cancer Therapeutics-a Phase I
• Department of Experimental Therapeutics
• University of Texas Health Science Center at Houston

External person

J. P. Eder

• Dana-Farber Cancer Institute
• Harvard University
• University of Arizona
• Yale Cancer Center
• Belfer Institute for Applied Cancer Science
• Division of Adult Oncology
• Department of Medicine (Section of Medical Oncology)
• Yale University
• Yale

External person

Danxia Ke

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Matthew G. Fury

• Regeneron Pharmaceuticals
• Regeneron Pharmaceuticals, Inc.

External person

K. Lawhorn

• Box 80
• Univ. of Pittsburgh Cancer Institute
• University of Texas M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• University of Pittsburgh
• Departments of Thoracic/Head and Neck Medical Oncology
• Department of Head and Neck Surgery
• Molecular Biology Laboratory

External person

John Thompson

• University of Washington
• Seattle Cancer Care Alliance
• Oncology Department
• Fred Hutchinson Cancer Research Center
• Harvard University
• National Institutes of Health
• Frederick National Laboratory Biomedical Applications Development Center (BADC)
• Massachusetts General Hospital Cancer Center
• Fred Hutchinson Cancer Research Center

External person

Jennifer S. Mammen

• University of Washington
• Johns Hopkins University

External person

Carrie A. Cartwright

• University of Texas MD Anderson Cancer Center
• Department of Cancer Biology
• Louisiana State University
• Departments of Experimental Therapeutics
• Cytokine Research Laboratory
• Pharmaceutical Development Center
• University of Texas Health Science Center at Houston

External person

S. C. Formenti

• Texas Univ. M.D. Anderson Can. Ctr.
• New York Univ. School of Medicine
• University of Southern California
• New York University
• New York University School of Med.
• University of Texas MD Anderson Cancer Center
• Cornell University
• Weill Cornell Medicine
• Weill Cornell Medicine
• Department of Radiation Oncology
• Departments of Radiation Oncology and Pathology
• Departments of Radiation Oncology
• Department of Radiation Oncology
• Department of Pathology
• Department of Radiation Oncology
• Department of Radiation Oncology and Meyer Cancer Center
• Weil Cornell College of Medicine
• New York Presbyterian Hospital
• Weill Cornell
• International Cancer Expert Corps, Inc.
• Weill Cornell Medical Center

External person

Selma Sulovic

• University of Texas MD Anderson Cancer Center

External person

Jeffrey S. Weber

• University of Southern California
• Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU
• University of South Florida
• Department of Cutaneous Oncology
• New York University
• Ohio State University
• Wexner Medical Center
• Department of Medicine/Oncology
• Department of Medicine
• Division of Medical Oncology
• Donald A. Adam Comprehensive Melanoma Research Center
• National Institutes of Health
• Surgery Branch
• Department of Medicine
• Moffitt Cancer Center

External person

Diego de Miguel-Perez

• University of Maryland, Baltimore
• Icahn School of Medicine at Mount Sinai
• University of Granada

External person

Ian Chau

• Royal Marsden Hospital, Sutton
• Royal Marsden Hospital London
• Department of Medicine, Royal Marsden Hospital
• Royal Marsden Hospital Surrey
• Royal Marsden Hospital
• Institute of Cancer Research
• Department of Medicine
• Department of Medicine
• Royal Marsden NHS Foundation Trust
• National Health Service
• Department of Medicine
• Royal Marsden Hospital
• Department of Surgery
• Erasmus University Rotterdam
• Royal Marsden Hospital
• The Institute of Cancer Research, London

External person

Laura D. Porter

• Colon Cancer Alliance
• DC
• NCI Colon Task Force

External person

Lee Rosen

• John Wayne Cancer Institute
• Premiere Oncology
• UCLA Division of Hematology Oncology
• UCLA
• The University of Chicago
• UCLA Department of Hematology and Oncology
• University of California at Los Angeles
• University of Texas MD Anderson Cancer Center
• Premiere Oncology
• Division of Hematology and Oncology
• Saint John's Health Center
• Santa Monica

External person

Muthukumar Gunasekaran

• University of Maryland, Baltimore
• Northwestern University

External person

Bianca D. Santomasso

• Memorial Sloan-Kettering Cancer Center
• Department of Neurology

External person

Maen Abdelrahim

• Baylor College of Medicine
• Texas A and M University System Health Science Center
• M.D. Anderson Cancer Center
• Orlando Regional Medical Center
• Texas A&M University
• Department of Internal Medicine, Baylor College of Medicine
• M.D. Anderson Cancer Center Orlando
• Department of Pathology
• University of Central Florida
• MD Anderson Cancer Center Orlando
• Texas AandM University Health Science Center
• Orlando Regional Health Care
• Duke University
• Institute of Biosciences and Technology
• Division of Medical Oncology
• Burnett School of Biomedical Sciences
• Cancer Research Institute
• Cancer Research Institute
• Orlando Regional Healthcare
• Institute for Academic Medicine
• Department of Internal Medicine
• Center for Epigenetics and Disease Prevention
• Inst. of Biosciences and Technology
• Center for Translational Cancer Research
• Dept Veterinary Physiology Pharmacol
• Insititute for Biosciences and Technology
• Weill Cornell Medical College
• Houston Methodist Weill Cornell Medical College
• Houston Methodist
• Institute of Academic Medicine and Weill Cornell Medical College
• Cornell University
• Houston Methodist
• Institute of Academic Medicine

External person

Vincent Yang

• University of Texas MD Anderson Cancer Center

External person

Deby C. Ogbonna

• University of Texas MD Anderson Cancer Center

External person

Navneet P. Ratti

• ARMO BioSciences
• Eli Lilly
• Synthkine
• a wholly owned subsidiary of Eli Lilly and Company

External person

Adoneca Fortier

• University of Texas MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Biostatistics
• University of Texas Health Science Center at Houston

External person

Carole Seigel

• Patient/Advocacy Representative
• University of Washington
• MA
• Harvard University
• Massachusetts General Hospital Cancer Center

External person

Marta Gil-Martin

• Autonomous University of Barcelona
• Medical Oncology Department
• Department of Medical Oncology
• Bellvitge Biomedical Research Institute
• Institute Catala Oncologia
• University of Barcelona
• Vall d'Hebron General Hospital
• Hospital de Bellvitge
• Hospital Durán i Reynals

External person

H. Henary

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Amgen Incorporated
• University of Texas Health Science Center at Houston

External person

Oscar Arrieta

• Hospital Universitario de la Universidad Autónoma de Nuevo León
• Instituto Nacional de Cancerología (INCan)
• Instituto Nacional de Cancerologia - Mexico
• Hospital Medica Sur Cif Biotec
• Fox Chase Cancer Center
• Thoracic Oncology Unit and Laboratory of Personalized Medicine
• Thoracic Oncology Unit and Laboratory
• Laboratory Medicine
• Clinic of Thoracic Oncology
• Experimental Oncology Laboratory
• Laboratorio de Oncología Experimental
• Unidad de Oncología Torácica
• Departamento de Oncología Medica
• Facultad de Medicina
• Universidad Nacional Autónoma de México
• División de Medicina
• Department of Medical Oncology
• Instituto Nacional de Ciencias
• Department of Oncology
• Medical Oncology Department
• Unidad de Cáncer de Mama
• Instituto Nacional de Cancerología (INCan)
• Personalized Medicine Laboratory
• INCAN
• Thoracic Oncology Functional Unit (UFOT)
• Universidad Nacional Autonoma de Mexico

External person

Sherry Pierce

• M.D. Anderson Cancer Center
• Univ. Texas M.D. Anderson Cancer C.
• University of Texas M.D. Anderson Cancer Center
• Box 61
• St. Vincent's Hospital Melbourne
• The University of Texas M.D. Anderson Cancer Center
• Department of Leukemia
• Unit 428
• University of Texas MD Anderson Cancer Center
• The University of Texas MD Anderson Cancer Center
• Univ. TX M. D. Anderson Cancer Ctr.
• UT MD Anderson Cancer Center
• Children's Memorial Hospital
• M. D. Anderson Cancer Center
• University of Washington
• University of South Florida
• U.T. M.D. Anderson Cancer Center
• Univ. TX M.D. Anderson Cancer Ctr.
• Singapore General Hospital
• Section of Molecular Hematology and Therapy, Department of Leukemia and Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer
• University of Texas at Austin
• 1515 Holcombe Blvd., Box 428, 77030
• Department of Leukemia, Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center
• Royal Melbourne Hospital
• University of Texas MD Anderson Cancer Center
• MDACC
• Departments of Leukemia
• Universidade Federal do Rio de Janeiro
• Department of Leukemia
• Departments of Leukemia
• Departments of Leukemia, Hematopathology, Biostatistics
• Depts. of Hematology and Pathology
• Department of Hematology
• Departments of Neurosurgery and Hematopathology
• Department of Leukemia
• Department of Leukemia and Department of Radiology
• Depts. Hematol. and Biomathematics
• Departments of Pediatrics and Leukemia
• Department of Leukemia
• Department of Stem Cell Transplantation
• Section of Leukemia
• Biostatistics and Biomathematics Group
• Department of Clinical Investigations
• Department of Hematopathology
• Chemoprevention Branch
• University of Texas Health Science Center at Houston
• Department of Leukemia
• Department of Leukemia

External person

Kenna R Mills Shaw

• National Institutes of Health
• University of Texas-Houston Health Science Center
• The University of Texas - Houston Health Science Center
• University of Texas MD Anderson Cancer Center
• Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
• Departments of Sheikh Khalifa Nahyan Ben Zayed
• Department of Gastrointestinal Medical Oncology
• Cancer Genome Atlas Program Office
• TCGA Genome Data Analysis Center
• Institute of Personalized Cancer Therapy
• Sheikh Khalifa Bin Zayed Al Nahyan
• University of Texas Health Science Center at Houston